About this FactMed analysis covering adverse side effect reports of ALIZAPRIDE patients who developed CANDIDIASIS.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 1 individuals taking ALIZAPRIDE reported CANDIDIASIS to the FDA. A total of 102 ALIZAPRIDE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ALIZAPRIDE and CANDIDIASIS. In doing so, we compare ALIZAPRIDE with other drugs that cause CANDIDIASIS, to help you evaluate whether or not ALIZAPRIDE causes CANDIDIASIS. Likewise, this page shows the most highly-reported side effects of ALIZAPRIDE, so you can see if CANDIDIASIS ranks among ALIZAPRIDE's most well-known side effects.
Summary Statistics
Reports of ALIZAPRIDE causing CANDIDIASIS: 1
Reports of any side effect of ALIZAPRIDE : 102
Percentage of ALIZAPRIDE patients where CANDIDIASIS is a reported side effect: 0.9804%

FDA reports of any drug causing CANDIDIASIS : 6397
Average percentage for all medicated patients where CANDIDIASIS is reported as a complication: 0.0401%

Physician opinion on ALIZAPRIDE as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ALIZAPRIDE:
DRUG USE FOR UNKNOWN INDICATION ( 14 patients )
NAUSEA ( 14 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 3 patients )
PREMEDICATION ( 2 patients )
VOMITING ( 2 patients )
ANTIEMETIC SUPPORTIVE CARE ( 2 patients )
PROPHYLAXIS ( 1 patients )
PROPHYLAXIS OF NAUSEA AND VOMITING ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with CANDIDIASIS:

FOSAMAX (970 patients)
ADVAIR DISKUS 100/50 (740 patients)
REMICADE (696 patients)
PREDNISONE (566 patients)
ASPIRIN (529 patients)
METHOTREXATE (417 patients)
VIOXX (413 patients)
HEPARIN SODIUM INJECTION (389 patients)
ZOMETA (385 patients)
NEXIUM (376 patients)
PREDNISOLONE (372 patients)
LASIX (352 patients)
COUMADIN (347 patients)
FLUCONAZOLE (339 patients)
ALBUTEROL (326 patients)
SPIRIVA (315 patients)
AREDIA (314 patients)
ACCUTANE (312 patients)
HUMIRA (311 patients)
DEXAMETHASONE (271 patients)
FOLIC ACID (253 patients)
SYNTHROID (247 patients)
PREDNISONE TAB (240 patients)
SINGULAIR (231 patients)
CYCLOPHOSPHAMIDE (230 patients)
OXYCONTIN (228 patients)
SEROQUEL (225 patients)
LEVAQUIN (225 patients)
PROTONIX (224 patients)
NEURONTIN (221 patients)
LIPITOR (219 patients)
PRILOSEC (213 patients)
AMBIEN (207 patients)
DECADRON (207 patients)
LEXAPRO (200 patients)
OMEPRAZOLE (197 patients)
PREVACID (194 patients)
LORAZEPAM (193 patients)
POTASSIUM CHLORIDE (192 patients)
ZOFRAN (190 patients)
ACETAMINOPHEN (189 patients)
MYCOPHENOLATE MOFETIL (186 patients)
FUROSEMIDE (186 patients)
DIFLUCAN (181 patients)
ZOCOR (176 patients)
XANAX (175 patients)
ZOLOFT (168 patients)
NYSTATIN (164 patients)
ATIVAN (163 patients)
LISINOPRIL (159 patients)
TACROLIMUS (155 patients)
CIPROFLOXACIN (155 patients)
CYMBALTA (154 patients)
SIMVASTATIN (152 patients)
REVLIMID (152 patients)
CYCLOSPORINE (151 patients)
VITAMIN D (146 patients)
NORVASC (146 patients)
VINCRISTINE (145 patients)
VICODIN (143 patients)
ATENOLOL (143 patients)
MULTI-VITAMINS (140 patients)
OXYCODONE HCL (140 patients)
HYDROCHLOROTHIAZIDE (139 patients)
GABAPENTIN (139 patients)
COMPAZINE (137 patients)
LEVOTHYROXINE SODIUM (136 patients)
ENBREL (136 patients)
ZYRTEC (134 patients)
PLAVIX (130 patients)
VANCOMYCIN (129 patients)
REGLAN (129 patients)
ACYCLOVIR (128 patients)
CELEXA (127 patients)
FENTANYL (127 patients)
CELEBREX (126 patients)
IBUPROFEN (125 patients)
ZANTAC (124 patients)
SYMBICORT (123 patients)
ALLOPURINOL (122 patients)
AUGMENTIN '125' (121 patients)
CARDIZEM (119 patients)
DIGOXIN (118 patients)
EFFEXOR (118 patients)
METHYLPREDNISOLONE (117 patients)
RIBAVIRIN (117 patients)
HIZENTRA (116 patients)
TAXOTERE (116 patients)
TYSABRI (115 patients)
PAXIL (114 patients)
MORPHINE (114 patients)
CYTARABINE (113 patients)
CLONAZEPAM (112 patients)
WELLBUTRIN (111 patients)
FLOVENT (111 patients)
ETOPOSIDE (110 patients)
ADVAIR HFA (109 patients)
PERCOCET (108 patients)
CALCIUM CARBONATE (106 patients)
FLONASE (106 patients)
PROGRAF (106 patients)
TOPROL-XL (105 patients)
CARBOPLATIN (105 patients)
AVELOX (104 patients)
METFORMIN HCL (103 patients)
XELODA (103 patients)
PREMARIN (100 patients)
CYTOXAN (100 patients)
NEUPOGEN (99 patients)
COMBIVENT (99 patients)
CISPLATIN (99 patients)
AMOXICILLIN (97 patients)
CALCIUM (97 patients)
BACTRIM (95 patients)
ZITHROMAX (95 patients)
HEPARIN (95 patients)
COLACE (95 patients)
ARANESP (94 patients)
VALIUM (94 patients)
FLUOROURACIL (94 patients)
HYDROCORTISONE (93 patients)
WARFARIN SODIUM (92 patients)
LANSOPRAZOLE (92 patients)
METOPROLOL TARTRATE (91 patients)
PROZAC (90 patients)
TAXOL (89 patients)
FLAGYL (88 patients)
RADIATION THERAPY (88 patients)
LEVOFLOXACIN (87 patients)
THALIDOMIDE (87 patients)
FLEXERIL (87 patients)
KEFLEX (87 patients)
CORDARONE (86 patients)
LOVENOX (86 patients)
FAMOTIDINE (86 patients)
SOLU-MEDROL (86 patients)
INSULIN (86 patients)
BENADRYL (84 patients)
DILAUDID (84 patients)
ASCORBIC ACID (83 patients)
OMNISCAN (83 patients)
NEORAL (83 patients)
CIPRO (82 patients)
LANTUS (81 patients)
CHEMOTHERAPEUTICS NOS (81 patients)
[THERAPY UNSPECIFIED] (80 patients)
MULTI-VITAMIN (80 patients)
VELCADE (77 patients)
RANITIDINE (77 patients)
OXYGEN (77 patients)
MS CONTIN (76 patients)
NITROGLYCERIN (76 patients)
ALPRAZOLAM (76 patients)
PANTOPRAZOLE (76 patients)
DURAGESIC-100 (76 patients)
DOXORUBICIN HCL (76 patients)
DIOVAN (75 patients)
RHEUMATREX (74 patients)
PEGASYS (74 patients)
NOVOLOG (73 patients)
LYRICA (73 patients)
CLARITIN (73 patients)
ACTONEL (73 patients)
ATROVENT (72 patients)
CRESTOR (72 patients)
ELAVIL (71 patients)
CLINDAMYCIN (71 patients)
PEPCID (71 patients)
ADRIAMYCIN PFS (71 patients)
OXYCODONE (70 patients)
METRONIDAZOLE (70 patients)
SEREVENT (70 patients)
ALLEGRA (69 patients)
VENTOLIN (69 patients)
LORTAB (69 patients)
LACTULOSE (68 patients)
NASONEX (68 patients)
VITAMIN E (67 patients)
XOPENEX (67 patients)
TEMAZEPAM (67 patients)
TYLENOL (67 patients)
LAMICTAL (67 patients)
ICL670A ICL+DISTAB (67 patients)
DOXYCYCLINE (66 patients)
RITUXIMAB (66 patients)
AVONEX (65 patients)
POTASSIUM (65 patients)
MAGNESIUM OXIDE (65 patients)
FLOMAX (65 patients)
VINCRISTINE SULFATE (65 patients)
SENNA (64 patients)
ONDANSETRON (63 patients)
PREDONINE (63 patients)
GEMZAR (63 patients)
FASLODEX (62 patients)
MEDROL (62 patients)
ULTRAM (62 patients)
GLUCOPHAGE (62 patients)
MORPHINE SULFATE (62 patients)
MEGACE (61 patients)
CLOTRIMAZOLE (61 patients)
PHENERGAN (61 patients)
CELLCEPT (60 patients)
COREG (59 patients)
MELPHALAN HYDROCHLORIDE (59 patients)
KLONOPIN (59 patients)
COZAAR (58 patients)
AZATHIOPRINE (58 patients)
MYCELEX (58 patients)
METOPROLOL (58 patients)
Most common side effects for patients taking ALIZAPRIDE:
DIARRHOEA (16 patients)
PYREXIA (16 patients)
VOMITING (10 patients)
FATIGUE (9 patients)
HYPOKALAEMIA (9 patients)
DEHYDRATION (8 patients)
NAUSEA (7 patients)
ANAEMIA (6 patients)
ASTHENIA (6 patients)
BRONCHOPNEUMONIA (6 patients)
DRUG INTERACTION (6 patients)
DYSPNOEA (6 patients)
HYPOTENSION (6 patients)
PNEUMONIA (6 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (5 patients)
HAEMORRHAGE (5 patients)
HYPOMAGNESAEMIA (5 patients)
HYPOPHOSPHATAEMIA (5 patients)
JAUNDICE (5 patients)
RESPIRATORY FAILURE (5 patients)
SOMNOLENCE (5 patients)
TACHYCARDIA (5 patients)
ABDOMINAL PAIN (4 patients)
ADVERSE DRUG REACTION (4 patients)
FALL (4 patients)
HAEMODIALYSIS (4 patients)
HAEMOGLOBIN DECREASED (4 patients)
INTESTINAL OBSTRUCTION (4 patients)
MALAISE (4 patients)
SLEEP APNOEA SYNDROME (4 patients)
SUPRAVENTRICULAR TACHYCARDIA (4 patients)
THROMBOCYTHAEMIA (4 patients)
THROMBOCYTOPENIA (4 patients)
WHITE BLOOD CELL COUNT DECREASED (4 patients)
ACUTE RESPIRATORY DISTRESS SYNDROME (3 patients)
BACTERIAL SEPSIS (3 patients)
BLOOD BILIRUBIN INCREASED (3 patients)
BLOOD CREATININE INCREASED (3 patients)
DECREASED APPETITE (3 patients)
DERMATITIS EXFOLIATIVE (3 patients)
DEVICE DISLOCATION (3 patients)
ENTERITIS (3 patients)
FEBRILE NEUTROPENIA (3 patients)
FIBRIN D DIMER INCREASED (3 patients)
FUSOBACTERIUM INFECTION (3 patients)
HAEMOPTYSIS (3 patients)
HYPOXIA (3 patients)
ILEUS (3 patients)
LEUKAEMIA RECURRENT (3 patients)
MUCOSAL INFLAMMATION (3 patients)
NEUROTOXICITY (3 patients)
NEUTROPENIA (3 patients)
OVERDOSE (3 patients)
PRESYNCOPE (3 patients)
PROTEUS INFECTION (3 patients)
RASH (3 patients)
RENAL FAILURE ACUTE (3 patients)
SEPTIC SHOCK (3 patients)
SUPERINFECTION (3 patients)
TONGUE DISORDER (3 patients)
ACUTE PULMONARY OEDEMA (2 patients)
AGRANULOCYTOSIS (2 patients)
ATRIAL FIBRILLATION (2 patients)
BLOOD FIBRINOGEN INCREASED (2 patients)
BLOOD GLUCOSE INCREASED (2 patients)
BONE MARROW DEPRESSION (2 patients)
BONE MARROW FAILURE (2 patients)
BRONCHOPULMONARY ASPERGILLOSIS (2 patients)
C-REACTIVE PROTEIN INCREASED (2 patients)
CHILLS (2 patients)
COLITIS ISCHAEMIC (2 patients)
CONSTIPATION (2 patients)
CONVULSION (2 patients)
CORONARY ARTERY DISEASE (2 patients)
DEAFNESS (2 patients)
DIZZINESS (2 patients)
DRUG ADMINISTRATION ERROR (2 patients)
DYSPHAGIA (2 patients)
DYSURIA (2 patients)
EJECTION FRACTION DECREASED (2 patients)
ERYSIPELAS (2 patients)
FACIAL PALSY (2 patients)
FEBRILE BONE MARROW APLASIA (2 patients)
FLATULENCE (2 patients)
GASTROENTERITIS (2 patients)
HAEMATOCRIT DECREASED (2 patients)
HYPERSENSITIVITY (2 patients)
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION (2 patients)
INFECTION (2 patients)
KLEBSIELLA SEPSIS (2 patients)
LEUKOPENIA (2 patients)
LYMPHANGITIS (2 patients)
LYMPHOCYTE COUNT INCREASED (2 patients)
NERVOUS SYSTEM DISORDER (2 patients)
NEUTROPHIL COUNT DECREASED (2 patients)
OEDEMA MUCOSAL (2 patients)
OTITIS MEDIA (2 patients)
PANCYTOPENIA (2 patients)
PARTIAL SEIZURES (2 patients)
PLATELET COUNT DECREASED (2 patients)
PULMONARY EMBOLISM (2 patients)
RED BLOOD CELL COUNT DECREASED (2 patients)
RENAL FAILURE (2 patients)
RHINORRHOEA (2 patients)
SHOCK (2 patients)
STREPTOCOCCAL SEPSIS (2 patients)
SUDDEN CARDIAC DEATH (2 patients)
URTICARIA (2 patients)
ACCIDENTAL OVERDOSE (1 patients)
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE (1 patients)
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN (1 patients)
AGITATION (1 patients)
ALVEOLITIS (1 patients)
ANOREXIA (1 patients)
ANXIETY (1 patients)
APHASIA (1 patients)
APHTHOUS STOMATITIS (1 patients)
ARACHNOIDITIS (1 patients)
BLOOD CULTURE POSITIVE (1 patients)
CALCULUS URINARY (1 patients)
CANDIDA SEPSIS (1 patients)
CANDIDIASIS (1 patients)
CARDIO-RESPIRATORY ARREST (1 patients)
CENTRAL NERVOUS SYSTEM LEUKAEMIA (1 patients)
CEREBRAL HAEMORRHAGE (1 patients)
CHEST PAIN (1 patients)
COLITIS (1 patients)
CONFUSIONAL STATE (1 patients)
COUGH (1 patients)
CYANOSIS (1 patients)
DIARRHOEA INFECTIOUS (1 patients)
DISEASE PROGRESSION (1 patients)
DISLOCATION OF VERTEBRA (1 patients)
DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED DRUG (1 patients)
DRUG HYPERSENSITIVITY (1 patients)
DRUG TOXICITY (1 patients)
DRY SKIN (1 patients)
ENCEPHALOPATHY (1 patients)
EPILEPSY (1 patients)
ERYTHEMA (1 patients)
FLUSHING (1 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (1 patients)
GENERAL PHYSICAL CONDITION ABNORMAL (1 patients)
GRAFT VERSUS HOST DISEASE (1 patients)
HAEMATURIA (1 patients)
HEADACHE (1 patients)
HYPERBILIRUBINAEMIA (1 patients)
HYPERTENSIVE CRISIS (1 patients)
HYPOACUSIS (1 patients)
HYPOAESTHESIA (1 patients)
HYPOCALCAEMIA (1 patients)
HYPOMANIA (1 patients)
HYPOVOLAEMIC SHOCK (1 patients)
KLEBSIELLA INFECTION (1 patients)
LACTOSE INTOLERANCE (1 patients)
LEUKAEMIA PLASMACYTIC (1 patients)
METASTATIC NEOPLASM (1 patients)
MULTI-ORGAN FAILURE (1 patients)
MULTIPLE MYELOMA (1 patients)
MUSCULAR WEAKNESS (1 patients)
MYALGIA (1 patients)
MYOGLOBIN BLOOD INCREASED (1 patients)
NEOPLASM (1 patients)
NEURALGIA (1 patients)
OEDEMA (1 patients)
OEDEMA PERIPHERAL (1 patients)
PAIN (1 patients)
PARESIS (1 patients)
PNEUMONIA KLEBSIELLA (1 patients)
PNEUMONITIS (1 patients)
PRODUCTIVE COUGH (1 patients)
PRURITUS (1 patients)
PULMONARY ALVEOLAR HAEMORRHAGE (1 patients)
PULMONARY HYPERTENSION (1 patients)
RADIUS FRACTURE (1 patients)
RASH GENERALISED (1 patients)
RASH MACULAR (1 patients)
RASH MACULO-PAPULAR (1 patients)
RENAL COLIC (1 patients)
RESPIRATORY DISTRESS (1 patients)
RIGHT VENTRICULAR DYSFUNCTION (1 patients)
SEPSIS (1 patients)
SKIN LESION (1 patients)
SPUTUM PURULENT (1 patients)
STAPHYLOCOCCAL BACTERAEMIA (1 patients)
STEM CELL TRANSPLANT (1 patients)
STOMATITIS (1 patients)
THROMBOSIS (1 patients)
THROMBOTIC MICROANGIOPATHY (1 patients)
TOXICITY TO VARIOUS AGENTS (1 patients)
ULNA FRACTURE (1 patients)
WEIGHT DECREASED (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ALIZAPRIDE


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about CANDIDIASIS and ALIZAPRIDE, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ALIZAPRIDE, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ALIZAPRIDE. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ALIZAPRIDE experts. If you are a healthcare provider experienced in prescribing ALIZAPRIDE, please register here.

Your online appointment book for Dallas Rentals & Services

© 2014 FactMed, Inc
Privacy Policy
Terms of Use